Compare Adaptive Biotechnologies Corp (ADPT) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs LTC Properties Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while LTC Properties Inc trades at $38.12 (market cap $2.05B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap, and LTC Properties Inc pays a 5.98% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LTC | |
|---|---|---|
Market Cap | $4.04B | $2.05B |
Sector | Health | Real Estate |
52-Week High | $25.45 | $42.81 |
52-Week Low | $12.30 | $33.98 |
Enterprise Value | $4.10B | $2.79B |
Dividend Yield | — | 5.98% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
